{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:47:29Z","timestamp":1790264849842,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T00:00:00Z","timestamp":1332288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10549-012-2019-3","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T10:24:18Z","timestamp":1332239058000},"page":"1169-1177","source":"Crossref","is-referenced-by-count":82,"title":["Benign thyroid disease is associated with breast cancer: a meta-analysis"],"prefix":"10.1007","volume":"133","author":[{"given":"Prue J.","family":"Hardefeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy D.","family":"Eslick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senarath","family":"Edirimanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14310\/horm.2002.1152","volume":"1","author":"N Sarlis","year":"2002","unstructured":"Sarlis N, Gourgiotis L, Pucino F, Tolis G (2002) Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones 1:35\u201341","journal-title":"Hormones"},{"key":"2019_CR2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/jc.81.3.990","volume":"81","author":"C Giani","year":"1996","unstructured":"Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990\u2013994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/ejso.2001.1204","volume":"27","author":"J Gogas","year":"2001","unstructured":"Gogas J, Kouskos E, Tseleni-Balafouta S et al (2001) Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 27:626\u2013630","journal-title":"Eur J Surg Oncol"},{"key":"2019_CR4","first-page":"1603","volume":"18","author":"J Jiskra","year":"2007","unstructured":"Jiskra J, Barkmanova J, Limanova Z et al (2007) Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival. Oncol Rep 18:1603\u20131611","journal-title":"Oncol Rep"},{"key":"2019_CR5","first-page":"149","volume":"16","author":"J Jiskra","year":"2003","unstructured":"Jiskra J, Limanova Z, Barkmanova J, Friedmannova Z (2003) Prevalence of autoimmune thyroid diseases in women with breast cancer in comparison with colorectal cancer. Klin Onkol 16:149\u2013153","journal-title":"Klin Onkol"},{"key":"2019_CR6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.20881","volume":"103","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Yamamura Y, Kau S-W et al (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122\u20131128","journal-title":"Cancer"},{"key":"2019_CR7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/thy.2005.15.1253","volume":"15","author":"JLP Kuijpens","year":"2005","unstructured":"Kuijpens JLP, Nyklictek I, Louwman MWJ, Weetman TAP, Pop VJM, Coebergh JWW (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15:1253\u20131259","journal-title":"Thyroid"},{"key":"2019_CR8","first-page":"157","volume":"25","author":"LS Singh","year":"1982","unstructured":"Singh LS, Lall BN, Agarwall GN (1982) Thyroid in breast cancer. Asian Med J 25:157\u2013163","journal-title":"Asian Med J"},{"key":"2019_CR9","first-page":"89","volume":"144","author":"HO Adami","year":"1978","unstructured":"Adami HO, Rimsten A, Thoren L, Vegelius J, Wide L (1978) Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand 144:89\u201397","journal-title":"Acta Chir Scand"},{"key":"2019_CR10","first-page":"1713","volume":"30","author":"N Ditsch","year":"2010","unstructured":"Ditsch N, Liebhardt S, Von Koch F et al (2010) Thyroid function in breast cancer patients. Anticancer Res 30:1713\u20131717","journal-title":"Anticancer Res"},{"key":"2019_CR11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1210\/jc.81.3.937","volume":"81","author":"PP Smyth","year":"1996","unstructured":"Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O\u2019Higgins NJ (1996) A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab 81:937\u2013941","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1097-0142(19860101)57:1<125::AID-CNCR2820570125>3.0.CO;2-4","volume":"57","author":"DA Adamopoulos","year":"1986","unstructured":"Adamopoulos DA, Vassilaros S, Kapolla N (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125\u2013128","journal-title":"Cancer"},{"key":"2019_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/bcr664","volume":"5","author":"O Turken","year":"2003","unstructured":"Turken O, NarIn Y, DemIrbas S et al (2003) Breast cancer in association with thyroid disorders. Breast Cancer Res 5:5","journal-title":"Breast Cancer Res"},{"key":"2019_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/er.2001-0029","volume":"24","author":"O Dohan","year":"2003","unstructured":"Dohan O, De La Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter C, Carrasco N (2003) The sodium\/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48\u201377","journal-title":"Endocr Rev"},{"key":"2019_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(96)00117-3","volume":"59","author":"CR Nogueira","year":"1996","unstructured":"Nogueira CR, Brentani MM (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59:271\u2013279","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019_CR16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/1097-0142(19901015)66:8<1759::AID-CNCR2820660820>3.0.CO;2-X","volume":"66","author":"H Miki","year":"1990","unstructured":"Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759\u20131762","journal-title":"Cancer"},{"key":"2019_CR17","first-page":"744","volume":"48","author":"SM Tavangar","year":"2007","unstructured":"Tavangar SM, Monajemzadeh M, Larijani B, Haghpanah V (2007) Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J 48:744\u2013747","journal-title":"Singapore Med J"},{"key":"2019_CR18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"key":"2019_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.1.6004.257","volume":"1","author":"I Mittra","year":"1976","unstructured":"Mittra I, Perrin J, Kumaoka S (1976) Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J 1:257\u2013259","journal-title":"Br Med J"},{"key":"2019_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-008-0104-4","volume":"115","author":"MK Sandhu","year":"2009","unstructured":"Sandhu MK, Brezden-Masley C, Lipscombe LL, Zagorski B, Booth GL (2009) Autoimmune hypothyroidism and breast cancer in the elderly. Breast Cancer Res Treat 115:635\u2013641","journal-title":"Breast Cancer Res Treat"},{"key":"2019_CR21","first-page":"1574","volume":"11","author":"MS Simon","year":"2002","unstructured":"Simon MS, Tang M-TC, Bernstein L et al (2002) Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 11:1574\u20131578","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019_CR22","first-page":"1329","volume":"78","author":"A Fukuda","year":"1987","unstructured":"Fukuda A, Hirohata T, Noguchi S, Ikeda M, Matsuo K, Yoshida A (1987) Risks for malignancies in patients with chronic thyroiditis: a long-term follow-up study. Jpn J Cancer Res 78:1329\u20131334","journal-title":"Jpn J Cancer Res"},{"key":"2019_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(81)90712-1","volume":"1","author":"AJ Hedley","year":"1981","unstructured":"Hedley AJ, Jones SJ, Spiegelhalter DJ et al (1981) Breast cancer in thyroid disease: fact or fallacy? Lancet 1:131\u2013133","journal-title":"Lancet"},{"key":"2019_CR24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(75)91006-5","volume":"2","author":"K Itoh","year":"1975","unstructured":"Itoh K, Maruchi N (1975) Breast cancer in patients with Hashimoto\u2019s thyroiditis. Lancet 2:1119\u20131121","journal-title":"Lancet"},{"key":"2019_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/519607","volume":"1","author":"I Muller","year":"2010","unstructured":"Muller I, Pinchera A, Fiore E et al (2010) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 1:1","journal-title":"J Endocrinol Invest"},{"key":"2019_CR26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000227093","volume":"49","author":"MB Goldman","year":"1992","unstructured":"Goldman MB, Monson RR, Maloof F (1992) Benign thyroid diseases and the risk of death from breast cancer. Oncology 49:461\u2013466","journal-title":"Oncology"},{"key":"2019_CR27","first-page":"263","volume":"51","author":"N Maruchi","year":"1976","unstructured":"Maruchi N, Annegers JF, Kurland LT (1976) Hashimoto\u2019s thyroiditis and breast cancer. Mayo Clin Proc 51:263\u2013265","journal-title":"Mayo Clin Proc"},{"key":"2019_CR28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF03348865","volume":"16","author":"PP Smyth","year":"1993","unstructured":"Smyth PP (1993) Thyroid disease and breast cancer. J Endocrinol Invest 16:396\u2013401","journal-title":"J Endocrinol Invest"},{"key":"2019_CR29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.02108","volume":"154","author":"E Giustarini","year":"2006","unstructured":"Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645\u2013649","journal-title":"Eur J Endocrinol"},{"key":"2019_CR30","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.83.8.2711","volume":"83","author":"PP Smyth","year":"1998","unstructured":"Smyth PP, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711\u20132716","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0277-5379(87)90319-1","volume":"23","author":"B Rasmusson","year":"1987","unstructured":"Rasmusson B, Feldt-Rasmussen U, Hegedus L, Perrild H, Bech K, Hoier-Madsen M (1987) Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 23:553\u2013556","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2019_CR32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/ije\/22.6.1000","volume":"22","author":"M Moseson","year":"1993","unstructured":"Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22:1000\u20131009","journal-title":"Int J Epidemiol"},{"key":"2019_CR33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/bjc.1997.289","volume":"75","author":"R Talamini","year":"1997","unstructured":"Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699\u20131703","journal-title":"Br J Cancer"},{"key":"2019_CR34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0021-9681(84)90062-6","volume":"37","author":"LA Brinton","year":"1984","unstructured":"Brinton LA, Hoffman DA, Hoover R, Fraumeni JF Jr (1984) Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis 37:877\u2013893","journal-title":"J Chronic Dis"},{"key":"2019_CR35","first-page":"139","volume":"17","author":"JW Finley","year":"1960","unstructured":"Finley JW, Bogardus GM (1960) Breast cancer and thyroid disease. Q Rev Surg Obstet Gynecol 17:139\u2013147","journal-title":"Q Rev Surg Obstet Gynecol"},{"key":"2019_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1507-1367(04)71016-0","volume":"9","author":"S Grodecka-Gazdecka","year":"2004","unstructured":"Grodecka-Gazdecka S, Lacka K, Graja T, Wawrzyniak M (2004) Examination of the breast in women treated for nodular thyroid disorders. Rep Pract Oncol Radiother 9:105\u2013108","journal-title":"Rep Pract Oncol Radiother"},{"key":"2019_CR37","first-page":"1607","volume":"29","author":"Y Nio","year":"2009","unstructured":"Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29:1607\u20131610","journal-title":"Anticancer Res"},{"key":"2019_CR38","first-page":"2283","volume":"50","author":"MB Goldman","year":"1990","unstructured":"Goldman MB, Monson RR, Maloof F (1990) Cancer mortality in women with thyroid disease. Cancer Res 50:2283\u20132289","journal-title":"Cancer Res"},{"key":"2019_CR39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/1097-0142(196409)17:9<1174::AID-CNCR2820170913>3.0.CO;2-C","volume":"17","author":"K Backwinkel","year":"1964","unstructured":"Backwinkel K, Jackson AS (1964) Some features of breast cancer and thyroid deficiency. Report of 280 cases. Cancer 17:1174\u20131176","journal-title":"Cancer"},{"key":"2019_CR40","first-page":"487","volume":"33","author":"T Kataoka","year":"1984","unstructured":"Kataoka T, Nishiki M, Yamane M, Amano K, Okumichi T, Ezaki H (1984) Thyroid disease and breast cancer. Hiroshima J Med Sci 33:487\u2013492","journal-title":"Hiroshima J Med Sci"},{"key":"2019_CR41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1055-9965.EPI-08-0911","volume":"18","author":"AI Hellevik","year":"2009","unstructured":"Hellevik AI, Asvold BO, Bjoro T, Romundstad PR, Nilsen TIL, Vatten LJ (2009) Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 18:570\u2013574","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019_CR42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/bjs.1800690731","volume":"69","author":"A Kalache","year":"1982","unstructured":"Kalache A, Vessey MP, McPherson K (1982) Thyroid disease and breast cancer: findings in a large case-control study. Br J Surg 69:434\u2013435","journal-title":"Br J Surg"},{"key":"2019_CR43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/sj.bjc.6605624","volume":"102","author":"X Shu","year":"2010","unstructured":"Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk in patients hospitalised for Graves disease: a population-based cohort study in Sweden. Br J Cancer 102:1397\u20131399","journal-title":"Br J Cancer"},{"key":"2019_CR44","unstructured":"Purde M, Tekkel M, Hint E, Ple\u0161ko I, Dimitrova E, Kramarova E, Cichy A, Vlasak V, Linhartova M (1990) Comparative study of breast cancer risk factors in Estonia and Slovakia. Neoplasma 37:97\u2013104"},{"key":"2019_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jso.20071","volume":"87","author":"O Cengiz","year":"2004","unstructured":"Cengiz O, Bozkurt B, Unal B et al (2004) The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 87:19\u201325","journal-title":"J Surg Oncol"},{"key":"2019_CR46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0277-5379(90)90151-I","volume":"26","author":"S Franceschi","year":"1990","unstructured":"Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781\u2013785","journal-title":"Eur J Cancer"},{"key":"2019_CR47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/bjc.1980.73","volume":"41","author":"IA MacFarlane","year":"1980","unstructured":"MacFarlane IA, Robinson EL, Bush H et al (1980) Thyroid function in patients with benign and malignant breast disease. Br J Cancer 41:478\u2013480","journal-title":"Br J Cancer"},{"key":"2019_CR48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0100-879X2005000500014","volume":"38","author":"PP Saraiva","year":"2005","unstructured":"Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761\u2013765","journal-title":"Braz J Med Biol Res"},{"key":"2019_CR49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0021-9681(68)90039-8","volume":"21","author":"D Schottenfeld","year":"1968","unstructured":"Schottenfeld D (1968) The relationship of breast cancer to thyroid disease. J Chronic Dis 21:303\u2013313","journal-title":"J Chronic Dis"},{"key":"2019_CR50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ije\/28.5.816","volume":"28","author":"HA Weiss","year":"1999","unstructured":"Weiss HA, Brinton LA, Potischman NA et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816\u2013823","journal-title":"Int J Epidemiol"},{"key":"2019_CR51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1210\/jcem-40-5-795","volume":"40","author":"DA Fisher","year":"1975","unstructured":"Fisher DA, Oddie TH, Johnson DE, Nelson JC (1975) The Diagnosis of Hashimoto\u2019s Thyroiditis. J Clin Endocrinol Metab 40:795\u2013801","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/biof.5520190304","volume":"19","author":"PPA Smyth","year":"2003","unstructured":"Smyth PPA (2003) Role of iodine in antioxidant defence in thyroid and breast disease. BioFactors 19:121\u2013130","journal-title":"BioFactors"},{"key":"2019_CR53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/78630","volume":"6","author":"U Tazebay","year":"2000","unstructured":"Tazebay U, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta P, Fineberg S, Pestell R, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871\u2013878","journal-title":"Nat Med"},{"key":"2019_CR54","first-page":"6526","volume":"60","author":"C Spitzweg","year":"2000","unstructured":"Spitzweg C, O\u2019Connor MK, Bergert ER, Tindall DJ, Young CYF, Morris JC (2000) Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60:6526\u20136530","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2019-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2019-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2019-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:34:01Z","timestamp":1559234041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2019-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2019-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,21]]}}}